We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

167 hedge funds and large institutions have $1.39B invested in Aerie Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $6.21M

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

28% more capital invested

Capital invested by funds: $1.09B → $1.39B (+$304M)

28% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 47

0% more funds holding

Funds holding: 167 → 167 (0)

0% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 36

Holders
167
Holders Change
–
Holders Change %
0%
% of All Funds
3.29%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.16%
New
36
Increased
60
Reduced
47
Closed
36
Calls
$17.2M
Puts
$6.21M
Net Calls
+$11M
Net Calls Change
+$1.8M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$23.7M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$22.8M
3
Bank of America
Bank of America
North Carolina
+$22.8M
4
Citigroup
Citigroup
New York
+$19.1M
5
PHS
PFM Health Sciences
California
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$57.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$27.2M
3
WRF
Waddell & Reed Financial
Kansas
-$20.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.5M
5
Goldman Sachs
Goldman Sachs
New York
-$7.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
51
Schonfeld Strategic Advisors
New York
$4.35M +$1.91M +92,248 +105%
PPA
52
Parametric Portfolio Associates
Washington
$4.14M +$849K +40,986 +31%
Alyeska Investment Group
53
Alyeska Investment Group
Illinois
$4.03M +$13.1K +632 +0.4%
AAP
54
Ardsley Advisory Partners
Connecticut
$3.75M +$3.21M +155,000 New
American Century Companies
55
American Century Companies
Missouri
$3.5M +$604K +29,157 +25%
KCM
56
Kornitzer Capital Management
Kansas
$3.45M -$2.91M -140,735 -50%
Renaissance Technologies
57
Renaissance Technologies
New York
$3.4M +$1.15M +55,600 +65%
CSS
58
Cubist Systematic Strategies
Connecticut
$3.08M +$1.65M +79,464 +165%
Stifel Financial
59
Stifel Financial
Missouri
$3.08M -$455K -21,987 -15%
AGA
60
Altrinsic Global Advisors
Connecticut
$2.9M – – –
PIM
61
Platinum Investment Management
Australia
$2.75M +$232K +11,193 +11%
CF
62
CNA Financial
Illinois
$2.63M -$1.4M -67,497 -38%
JG
63
Jefferies Group
New York
$2.47M +$2.11M +102,077 New
EIM
64
Essex Investment Management
Massachusetts
$2.42M +$2.07M +100,000 New
Goldman Sachs
65
Goldman Sachs
New York
$2.21M -$7.41M -357,539 -80%
California Public Employees Retirement System
66
California Public Employees Retirement System
California
$2.12M +$362K +17,500 +25%
TRSOTSOK
67
Teachers Retirement System of the State of Kentucky
Kentucky
$2.04M – – –
Swiss National Bank
68
Swiss National Bank
Switzerland
$2.02M +$33.1K +1,600 +2%
Squarepoint
69
Squarepoint
New York
$1.97M -$1.75M -84,466 -51%
JP Morgan Chase
70
JP Morgan Chase
New York
$1.94M +$1.37M +66,285 +479%
CIC
71
Chilton Investment Company
Connecticut
$1.62M +$373K +17,995 +37%
TCM
72
Tekla Capital Management
Massachusetts
$1.61M – – –
California State Teachers Retirement System (CalSTRS)
73
California State Teachers Retirement System (CalSTRS)
California
$1.56M -$27K -1,303 -2%
State of Wisconsin Investment Board
74
State of Wisconsin Investment Board
Wisconsin
$1.53M – – –
ACM
75
Asymmetry Capital Management
California
$1.51M +$1.29M +62,507 New
1 2
3
4 5

AERI Hedge Fund Activity: Q4 2019 in Review

167 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2019, worth a combined $1.39B — up 28% from $1.09B a quarter earlier.

Fund positioning in AERI was balanced in Q4 2019: 36 funds opened new positions, 36 closed out, 60 added to existing stakes and 47 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $23.7M. The largest seller was Deerfield Management, cutting an estimated $57.9M.

  • 167 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $1.39B of Aerie Pharmaceuticals stock for Q4 2019, up 28% quarter-over-quarter.
  • 36 funds opened new Aerie Pharmaceuticals positions in Q4 2019 and 36 closed out, a net change of 0 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2019 was Franklin Resources, an estimated $23.7M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2019 was Deerfield Management, an estimated $57.9M sold.

Based on aggregated 13F filings for Q4 2019.